Goldman Sachs’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
283,236
-62,351
-18% -$52.6K ﹤0.01% 6038
2025
Q4
$271K Sell
345,587
-342,578
-50% -$281K ﹤0.01% 5915
2025
Q3
$496K Buy
688,165
+651,890
+1,797% +$2.95M ﹤0.01% 5518
2025
Q2
$184K Sell
36,275
-346,042
-91% -$1.36M ﹤0.01% 5687
2025
Q1
$1.15M Buy
382,317
+120,496
+46% +$439K ﹤0.01% 4572
2024
Q4
$948K Buy
+261,821
New +$793K ﹤0.01% 4859
2024
Q2
Sell
-217,233
Closed -$424K 5982
2024
Q1
$424K Buy
217,233
+73,663
+51% +$128K ﹤0.01% 4824
2023
Q4
$202K Buy
+143,570
New +$184K ﹤0.01% 5149
2022
Q1
Sell
-18,512
Closed -$138K 6965
2021
Q4
$138K Buy
+18,512
New +$154K ﹤0.01% 6031
2017
Q3
Sell
-1,582
Closed -$75K 6896
2017
Q2
$75K Sell
1,582
-709
-31% -$33.2K ﹤0.01% 6235
2017
Q1
$112K Sell
2,291
-3,313
-59% -$151K ﹤0.01% 6013
2016
Q4
$169K Sell
5,604
-1,048
-16% -$43K ﹤0.01% 5880
2016
Q3
$296K Buy
6,652
+4,305
+183% +$186K ﹤0.01% 5492
2016
Q2
$91K Sell
2,347
-707
-23% -$32.9K ﹤0.01% 6175
2016
Q1
$168K Buy
3,054
+2,100
+220% +$160K ﹤0.01% 5756
2015
Q4
$131K Sell
954
-3,292
-78% -$468K ﹤0.01% 6021
2015
Q3
$610K Sell
4,246
-1,291
-23% -$294K ﹤0.01% 4946
2015
Q2
$1.44M Buy
+5,537
New +$1.72M ﹤0.01% 4182

Other funds holding ATYR